Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis
- PMID: 9396704
- DOI: 10.1086/513787
Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis
Abstract
Experimental allergic neuritis (EAN) is considered the in vivo model of Guillain-Barré syndrome (GBS) and has been extensively studied in the Lewis rat. Both cellular and humoral components of the immune response are implicated in the inflammatory demyelination of peripheral nerves that characterizes EAN. The recognition of Campylobacter jejuni infection as a frequent antecedent event in GBS, and in particular its association with anti-ganglioside antibodies and a primary axonal neuropathy, has raised many questions about the specific disease mechanisms involved. While C. jejuni can produce an acute motor neuropathy in chickens, confirming the relationship between C. jejuni infection and acute neuropathy, no detailed information is available from this animal model. Insights from experimental studies relating to the effector phase of Lewis rat EAN that may be relevant to C. jejuni-induced GBS are discussed.
Similar articles
-
P2-reactive T cells in inflammatory demyelination of the peripheral nerve.J Infect Dis. 1997 Dec;176 Suppl 2:S160-3. doi: 10.1086/513794. J Infect Dis. 1997. PMID: 9396703 Review.
-
Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.J Neuroimmunol. 1998 Jan;81(1-2):138-43. doi: 10.1016/s0165-5728(97)00168-9. J Neuroimmunol. 1998. PMID: 9521615
-
Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.J Infect Dis. 1997 Dec;176 Suppl 2:S150-3. doi: 10.1086/513800. J Infect Dis. 1997. PMID: 9396700 Review.
-
Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome?Neurosci Lett. 2005 Jun 10-17;381(1-2):175-8. doi: 10.1016/j.neulet.2005.02.028. Epub 2005 Feb 25. Neurosci Lett. 2005. PMID: 15882812
-
Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.J Neuroimmunol. 1998 Jan;81(1-2):116-26. doi: 10.1016/s0165-5728(97)00166-5. J Neuroimmunol. 1998. PMID: 9521613
Cited by
-
Campylobacter jejuni virulence factors: update on emerging issues and trends.J Biomed Sci. 2024 May 1;31(1):45. doi: 10.1186/s12929-024-01033-6. J Biomed Sci. 2024. PMID: 38693534 Free PMC article. Review.
-
Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.Mediators Inflamm. 2014;2014:758639. doi: 10.1155/2014/758639. Epub 2014 Sep 22. Mediators Inflamm. 2014. PMID: 25614713 Free PMC article. Review.
-
Campylobacter in Africa - A specific viewpoint.Eur J Microbiol Immunol (Bp). 2023 Dec 5;13(4):107-124. doi: 10.1556/1886.2023.00043. Print 2023 Dec 21. Eur J Microbiol Immunol (Bp). 2023. PMID: 38051352 Free PMC article. Review.
-
Campylobacter species and Guillain-Barré syndrome.Clin Microbiol Rev. 1998 Jul;11(3):555-67. doi: 10.1128/CMR.11.3.555. Clin Microbiol Rev. 1998. PMID: 9665983 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical